Revenue: The sum of all revenue fields included for a company's operating activities.
Nurix Therapeutics, Inc. (NRIX) had Revenue of $44.06M for the most recently reported fiscal quarter, ending 2025-05-31.
| Income Statement Financials | |
|
Revenue |
$44.06M |
$-43.46M |
|
-- |
|
$44.06M |
|
$92.38M |
|
$-48.32M |
|
$5.62M |
|
$-42.70M |
|
$-42.70M |
|
$-43.46M |
|
$-43.46M |
|
$-43.46M |
|
$-43.46M |
|
$-48.32M |
|
$-43.23M |
|
83.88M |
|
83.88M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$515.33M |
|
$18.77M |
|
$76.22M |
|
$591.55M |
|
$75.61M |
|
-- |
|
$68.34M |
|
$143.95M |
|
$447.60M |
|
$447.60M |
|
$447.60M |
|
76.43M |
|
| Cash Flow Statement Financials | |
$-124.25M |
|
$97.03M |
|
$1.48M |
|
$110.90M |
|
$85.16M |
|
$-25.74M |
|
$19.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-109.68% |
|
-109.68% |
|
-- |
|
-96.93% |
|
-98.66% |
|
$-130.41M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
2.32 |
|
38.81 |
|
-9.71% |
|
-9.71% |
|
-7.35% |
|
-9.71% |
|
$5.86 |
|
$-1.55 |
|
$-1.48 |
|